Apollon Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.93M | Sell |
12,153
-6,743
| -36% | -$2.73M | 0.1% | 187 |
|
|
2025
Q1 | $9.4M | Buy |
18,896
+5,997
| +46% | +$2.98M | 0.21% | 94 |
|
|
2024
Q4 | $6.71M | Buy |
12,899
+1,857
| +17% | +$966K | 0.15% | 120 |
|
|
2024
Q3 | $6.83M | Buy |
11,042
+423
| +4% | +$262K | 0.19% | 93 |
|
|
2024
Q2 | $5.87M | Sell |
10,619
-159
| -1% | -$87.9K | 0.18% | 105 |
|
|
2024
Q1 | $6.26M | Buy |
10,778
+973
| +10% | +$566K | 0.2% | 93 |
|
|
2023
Q4 | $5.2M | Buy |
9,805
+1,067
| +12% | +$566K | 0.18% | 104 |
|
|
2023
Q3 | $4.42M | Sell |
8,738
-434
| -5% | -$220K | 0.22% | 83 |
|
|
2023
Q2 | $4.79M | Buy |
9,172
+1,473
| +19% | +$769K | 0.23% | 92 |
|
|
2023
Q1 | $4.44M | Sell |
7,699
-728
| -9% | -$420K | 0.27% | 77 |
|
|
2022
Q4 | $4.64M | Buy |
8,427
+178
| +2% | +$98K | 0.33% | 62 |
|
|
2022
Q3 | $4.18M | Buy |
8,249
+19
| +0.2% | +$9.64K | 0.34% | 57 |
|
|
2022
Q2 | $4.47M | Buy |
8,230
+184
| +2% | +$100K | 0.37% | 50 |
|
|
2022
Q1 | $4.75M | Sell |
8,046
-92
| -1% | -$54.3K | 0.34% | 61 |
|
|
2021
Q4 | $5.43M | Buy |
8,138
+1,685
| +26% | +$1.12M | 0.41% | 50 |
|
|
2021
Q3 | $3.69M | Buy |
6,453
+332
| +5% | +$190K | 0.51% | 39 |
|
|
2021
Q2 | $3.09M | Buy |
6,121
+104
| +2% | +$52.5K | 0.55% | 41 |
|
|
2021
Q1 | $2.75M | Buy |
6,017
+4,477
| +291% | +$2.04M | 0.53% | 44 |
|
|
2020
Q4 | $717K | Sell |
1,540
-531
| -26% | -$247K | 0.19% | 102 |
|
|
2020
Q3 | $914K | Buy |
2,071
+1,109
| +115% | +$489K | 0.41% | 61 |
|
|
2020
Q2 | $348K | Buy |
+962
| New | +$348K | 0.19% | 68 |
|